Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Madrigal Pharmaceuticals, Inc. - Common Stock (NQ:MDGL)

485.76 -11.51 (-2.31%)

Streaming Delayed Price Updated: 2:27 PM EDT, Jun 1, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	128,835
Open	495.74
Bid (Size)	485.56 (40)
Ask (Size)	488.09 (80)
Prev. Close	497.27
Today's Range	479.00 - 496.07
52wk Range	268.69 - 615.00
Shares Outstanding	17,103,395
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Why This Fund Made a $189 Million Bet on Erasca as Shares Skyrocket 800% ↗

May 29, 2026

This clinical-stage biotech develops targeted oral therapies for RAS/MAPK-driven cancers, with all assets currently in development.

Via The Motley Fool

Tango Therapeutics Stock Is Up 840%, and This Fund Just Disclosed Buying $164 Million More ↗

May 29, 2026

This biotechnology firm advances targeted cancer therapies, leveraging genetic insights and strategic partnerships in oncology.

Via The Motley Fool

Performance

YTD	-18.2%	-18.2%
1 Month	-5.4%	-5.4%
3 Month	+11.5%	+11.5%
6 Month	-16.2%	-16.2%
1 Year	+78.1%	+78.1%

More News

Arrowhead (ARWR) Q2 2026 Earnings Transcript ↗

May 08, 2026

Via The Motley Fool

Madrigal Pharmaceuticals (NASDAQ:MDGL) Shares Dip Despite Q1 2026 Earnings Beat and 127% Rezdiffra Revenue Growth ↗

May 06, 2026

Via Chartmill

Madrigal Pharmaceuticals Inc (NASDAQ:MDGL) Reports Q4 2025 Revenue Beat and Significant EPS Miss ↗

February 19, 2026

Via Chartmill

Madrigal (MDGL) Q1 2026 Earnings Transcript ↗

May 06, 2026

Via The Motley Fool

3 Under-the-Radar Healthcare Stocks Worth Adding to Your Watchlist ↗

April 16, 2026

Via The Motley Fool

Prediction: 2 Stocks That Will Be Worth More Than Summit Therapeutics 1 Year From Now ↗

March 25, 2026

Via The Motley Fool

Madrigal Doubles Down On MASH With A $4.4 Billion Licensing Deal With China’s Ribo ↗

February 11, 2026

Via Stocktwits

This New $193 Million Bet Targets a Biotech With $689 Million in Revenue and a Potential Turnaround Story ↗

March 21, 2026

Via The Motley Fool

This $116 Million Buy Joins a 360% Stock Run and Seemingly Signals Conviction in a Key Drug Launch ↗

March 21, 2026

Via The Motley Fool

This Specialized Heart Monitor Maker Just Caught the Eye of a Major Healthcare Fund ↗

March 20, 2026

Via The Motley Fool

2 Under-the-Radar Stocks to Buy and Hold ↗

March 10, 2026

Via The Motley Fool

Madrigal (MDGL) Q4 2025 Earnings Call Transcript ↗

February 23, 2026

Via The Motley Fool

Investor Buys Up $81 Million in Praxis Stock as Shares Soar Over 300% in One Year ↗

February 23, 2026

Via The Motley Fool

This Fund Bet Nearly $40 Million on GRAIL Last Quarter. The Stock Just Plunged Over 50% ↗

February 23, 2026

Via The Motley Fool

Agios Stock Down 16% in a Year as Fund Cuts Stake by $5.6 Million After 50% November Crash ↗

February 17, 2026

Via The Motley Fool

Cogent Biosciences Stock Soars 346% in a Year, but One Fund Just Sold Off $4.5 Million ↗

February 17, 2026

Via The Motley Fool

Structure Therapeutics Stock Up 187% in One Year as Fund Trims $8 Million From Stake ↗

February 17, 2026

Via The Motley Fool

Kymera Therapeutics Stock Up 120% in 1 Year as Fund Adds $3 Million More ↗

February 17, 2026

Via The Motley Fool

Why Madrigal Pharmaceuticals Stock Slumped on Tuesday ↗

January 06, 2026

Via The Motley Fool

Ignore Nektar Therapeutics Stock in 2026 and Load Up on This One Instead ↗

January 05, 2026

Via The Motley Fool

2 Tailwinds Behind Novo Nordisk Stock Heading Into 2026 ↗

January 03, 2026

Via The Motley Fool

2 Predictions for Novo Nordisk in 2026 ↗

December 14, 2025

Via The Motley Fool

2 Stocks Up Over 600% in the Past 3 Years With More Room to Run ↗

December 09, 2025

Via The Motley Fool

Frequently Asked Questions

Is Madrigal Pharmaceuticals, Inc. - Common Stock publicly traded?

Yes, Madrigal Pharmaceuticals, Inc. - Common Stock is publicly traded.

What exchange does Madrigal Pharmaceuticals, Inc. - Common Stock trade on?

Madrigal Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Madrigal Pharmaceuticals, Inc. - Common Stock?

The ticker symbol for Madrigal Pharmaceuticals, Inc. - Common Stock is MDGL on the Nasdaq Stock Market

What is the current price of Madrigal Pharmaceuticals, Inc. - Common Stock?

The current price of Madrigal Pharmaceuticals, Inc. - Common Stock is 485.76

When was Madrigal Pharmaceuticals, Inc. - Common Stock last traded?

The last trade of Madrigal Pharmaceuticals, Inc. - Common Stock was at 06/01/26 02:27 PM ET

What is the market capitalization of Madrigal Pharmaceuticals, Inc. - Common Stock?

The market capitalization of Madrigal Pharmaceuticals, Inc. - Common Stock is 8.31B

How many shares of Madrigal Pharmaceuticals, Inc. - Common Stock are outstanding?

Madrigal Pharmaceuticals, Inc. - Common Stock has 8B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.